Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
Clinical trial NCT05015010 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05015010
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-20
- Primary completion
- 2024-12-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.